Autopsy report · NCT01619449
Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant
Cause of deathSlow enrollment, also regulatory or ethics
“Research never begun and no subjects enrolled. Protocol term with IRB in Dec 2014”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- University of Chicago
- Sponsor type
- University, hospital or other
- Conditions
- Acute Kidney Injury; Liver Disease; Chronic Kidney Disease; End Stage Kidney Disease
- Interventions
- Renal replacement therapy
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
“Study did not receive IRB approval, so did not start” - Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral
“Study was never initiated. No IRB approval obtained, and no participants enrolled.” - Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer
“The study was never initiated, no patients were enrolled. It has been closed with the IRB.” - Study Comparing Intubation Via Video Laryngeal Mask Airways (VLMAs) Versus Video Laryngoscopy
“Study never approved by the IRB. Was not initiated” - Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
“This study was never submitted to the IRB for review and approval. No research subjects were enrolled. .”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.